BioInvent International AB (publ) (LON:0H22)
London flag London · Delayed Price · Currency is GBP · Price in SEK
29.73
+0.13 (0.42%)
At close: Sep 12, 2025

LON:0H22 Revenue

BioInvent International AB had revenue of 198.10M SEK in the quarter ending June 30, 2025, with 4,196.20% growth. This brings the company's revenue in the last twelve months to 254.29M, up 382.81% year-over-year. In the year 2024, BioInvent International AB had annual revenue of 44.69M, down -37.47%.

Revenue (ttm)
254.29M SEK
Revenue Growth
+382.81%
P/S Ratio
8.23
Revenue / Employee
2.23M SEK
Employees
114
Market Cap
160.58M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202444.69M-26.78M-37.47%
Dec 31, 202371.46M-254.67M-78.09%
Dec 31, 2022326.13M306.74M1,582.45%
Dec 31, 202119.38M-127.99M-86.85%
Dec 31, 2020147.37M53.63M57.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc31.63B
Haleon11.02B
Smith & Nephew4.33B
ConvaTec Group1.72B
Hikma Pharmaceuticals2.35B
HUTCHMED (China)439.54M
Genus672.80M
Revenue Rankings